Role of solute carrier transporters SLC25A17 and SLC27A6 in acquired resistance to enzalutamide in castration-resistant prostate cancer

Kushwaha, PP; Verma, SS; Shankar, E; Lin, S; Gupta, S

Gupta, S (通讯作者)，Case Western Reserve Univ, Dept Urol, Cleveland, OH 44106 USA.;Gupta, S (通讯作者)，Case Western Reserve Univ, Dept Urol, James & Eilleen Dicke Res Lab, 10900 Euclid Ave, Cleveland, OH 44106 USA.

MOLECULAR CARCINOGENESIS, 2022; 61 (4): 397

Abstract

Enzalutamide (XTANDI (R)), an antiandrogen, is used for the treatment of advanced-stage prostate cancer. Approximately, 60% of patients receiving enza......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索